# OnCo record paper-splash-front-oncol-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-splash-front-oncol-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-splash-front-oncol-2024" ;
  schema:name "Initial clinical experience with [ 177 Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial"@en ;
  schema:description "Published report from the SPLASH trial registered as NCT04647526, in Frontiers in oncology (2024), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-splash-front-oncol-2024/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.3389/fonc.2024.1483953>, <https://pubmed.ncbi.nlm.nih.gov/39839782/>, <https://europepmc.org/article/MED/39839782>, <https://clinicaltrials.gov/study/NCT04647526> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.3389/fonc.2024.1483953> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Hansen AR, Probst S, Beauregard JM, et al." ;
  onco:trials <https://onco.cc/trials/splash/> .